Relapse after glofitamab has a poor prognosis and rates of CD20 loss are high. Grigg S, Minson A, Prins E, Dickinson MJ, et al. Br J Haematol 2024;205:122-126.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Grigg S, Minson A, Prins E, Dickinson MJ, et al. Relapse after glofitamab has a poor prognosis and rates of CD20 loss are high. Br J Haematol 2024;205:122-126.
PMID: 38720530